Ubrelvy (ubrogepant) was approved by the U.S. Food and Drug Administration (FDA) on December 23, 2019 [1].
What is Ubrelvy used for?
Ubrelvy is a medication prescribed for the acute treatment of migraine with or without aura in adults [1]. It is not intended for the preventive treatment of migraine [1].
How does Ubrelvy work?
Ubrelvy is a calcitonin gene-related peptide (CGRP) receptor antagonist [1]. It works by blocking the activity of CGRP, a molecule that is thought to play a role in migraine attacks [2].
When might Ubrelvy patents expire?
Drug patent information can be complex and subject to change. For detailed information on Ubrelvy's patent expiration, including any potential for generic or biosimilar entry, resources like DrugPatentWatch.com are valuable [3].
Who makes Ubrelvy?
Ubrelvy is manufactured by AbbVie Inc [1].
What are the side effects of Ubrelvy?
The most common side effects reported in clinical trials included nausea and fatigue [1]. Less common side effects can also occur [1].
How does Ubrelvy compare to other migraine treatments?
Ubrelvy is an oral medication within the CGRP antagonist class, offering an alternative to other acute migraine treatments such as triptans and NSAIDs [2]. It provides a non-triptan option for patients who may not respond to or tolerate triptans [2].
What is the cost of Ubrelvy?
The cost of Ubrelvy can vary depending on insurance coverage and pharmacy pricing. Patient assistance programs may be available for eligible individuals [4].
Can Ubrelvy be used to prevent migraines?
No, Ubrelvy is indicated for the acute treatment of migraine attacks, not for preventing future migraines [1]. Preventive migraine treatments target different mechanisms and are typically taken on a regular schedule [1].
---
Sources:
1. https://www.fda.gov/drugs/drug-approvals/ubrelevy-ubrogepant-new-drug-approval-abbvie-inc
2. https://www.drugpatentwatch.com/blog/migraine-treatment-class-called-cgrp-antagonists
3. https://www.drugpatentwatch.com/
4. Information regarding the cost and patient assistance programs for prescription medications can typically be found on the manufacturer's website or through patient advocacy groups.